Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-033610
Filing Date
2018-06-08
Accepted
2018-06-08 17:27:51
Documents
1
Period of Report
2018-06-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv496094_4.html 4  
1 OWNERSHIP DOCUMENT tv496094_4.xml 4 4163
  Complete submission text file 0001144204-18-033610.txt   5533
Mailing Address C/O SICOR INC 19 HUGHES IRVINE CA 92618-1902
Business Address
CANNON MICHAEL D (Reporting) CIK: 0001203602 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37758 | Film No.: 18890476

Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations